Scientific Program

Track 1: Challenges and Regulatory Approach for Biosimilars

Chair

Jichao (Jay) Kang, Laureate Biopharmaceutical Services, USA

Chair

Kevin W. McCabe, Sterne, Kessler, Goldstein & Fox, USA

17:10-17:30

Break: 17:50-18:50 Cocktails Sponsored by Journal of Bioanalysis & Biomedicine @ Oak

Track-2: Emerging Biosimilars in Therapeutics

Chair

Russell Reeve, Quintiles Inc., USA

Chair

Subhash Basu, University of Notre Dame, USA

Track 3: Clinical Studies and Clinicians Prospects for Biosimilars
Track 4: Globalization of Biosimilars
Location: Magnolia

Chair

Steven Lehrer, Optimal Strategix Group, USA

Chair

Jennifer Campbell, Merck Millipore, France

Track 5: Biosimilars Innovator Pharmaceutical Products
Track 7: Bioequivalence Assessment
Track 8: BCS & IVIVC Based Biowaivers
Location: Magnolia

Chair

Ajay K. Banga, Mercer University, USA

Chair

Hu Yan, Zhengzhou University, China

Track 6: Analytical Strategies

Chair

Michael Retsky, Harvard School of Public Health, USA

Chair

Yunsheng Hsieh, Protech Pharmaservices Corporation, Taiwan